Novel somatic mutations in heterotrimeric G proteins in melanoma.

Heterotrimeric guanine nucleotide-binding proteins (G proteins) mediate signals between G-protein coupled receptors and their downstream pathways, and have been shown to be mutated in cancer. In particular, GNAQ was found to be frequently mutated in blue nevi of the skin and uveal melanoma, acting as an oncogene in its mutated form. To further examine the role of heterotrimeric G proteins in malignant melanoma, we performed a comprehensive mutational analysis of the 35 genes in the heterotrimeric G protein gene family in a panel of 80 melanoma samples. Somatic alterations in a G protein subunit were detected in 17% of samples spanning 7 genes. The highest rates of somatic, non-synonymous mutations were found in GNG10 and GNAZ, neither of which has been previously reported to be mutated in melanoma. Our study is the first systematic analysis of the heterotrimeric G proteins in melanoma and indicates that multiple mutated heterotrimeric G proteins may be involved in melanoma progression.
AuthorsL Isabel Cárdenas-Navia, Pedro Cruz, Jimmy C Lin, , Steven A Rosenberg, Yardena Samuels
JournalCancer biology & therapy (Cancer Biol Ther) Vol. 10 Issue 1 Pg. 33-7 (Jul 1 2010) ISSN: 1555-8576 [Electronic] United States
PMID20424519 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • DNA, Neoplasm
  • Heterotrimeric GTP-Binding Proteins
  • DNA Mutational Analysis
  • DNA, Neoplasm (genetics)
  • Heterotrimeric GTP-Binding Proteins (genetics)
  • Humans
  • Melanoma (genetics, pathology)
  • Mutation (genetics)
  • Polymerase Chain Reaction
  • Signal Transduction
  • Skin Neoplasms (genetics, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: